Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Diagonal Therapeutics, Inc.

Clinical trials sponsored by Diagonal Therapeutics, Inc., explained in plain language.

Trials to join now! 1

New antibody aims to tame rare bleeding disorder

Disease control Recruiting now

This early-phase trial tests an experimental antibody called DIAG723 in 93 adults with hereditary hemorrhagic telangiectasia (HHT), a condition that causes abnormal blood vessels and frequent nosebleeds. The study will check if the drug is safe and how the body processes it, with…

Phase 1/2 • Sponsor: Diagonal Therapeutics, Inc. • Aim: Disease control

Last updated Sep 10, 2026 00:00 UTC